Cite
HARVARD Citation
Sanchez-Garcia, J. et al. (n.d.). Modifications in Mutational Landscape in Patients with Lower Risk MDS without 5Q Deletion Receiving Azacitidine Are Correlated with Clinical Response. Leukemia research. pp. S73-S74. [Online].